Amiodarone: Clinical Trials

120 trials of Amiodarone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 26 unknown, 16 terminated, 12 recruiting. 38 Phase 3, 35 Phase 4, 26 Not applicable, 11 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 338Completed 16, Unknown 8, Recruiting 4, Terminated 4, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Suspended 1
Phase 435Completed 12, Unknown 10, Terminated 6, Recruiting 3, Not yet recruiting 2, Enrolling by invitation 1, Withdrawn 1
Not applicable26Completed 11, Terminated 6, Unknown 5, Not yet recruiting 2, Recruiting 2
Phase 211Completed 6, Withdrawn 3, Recruiting 1, Unknown 1
Phase 14Completed 2, Not yet recruiting 1, Unknown 1
Early Phase 12Recruiting 1, Unknown 1

Follow Amiodarone: new trials by email Literature Review of Amiodarone trials Research Report on Amiodarone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Amiodarone - Surgery, Cardiac, Atrial Fibrillation
Phase 4Not yet recruitingMassachusetts General Hospital2422027-01-012026-06-30
Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy.
Colchicine, Amiodarone, Posterior pericardiotomy - Atrial Fibrillation (AF)
Phase 3Not yet recruitingElsan6362027-01-012026-10-21
Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients
Vernakalant, Amiodarone - Atrial Fibrillation, Post-cardiac Surgery
Phase 3Not yet recruitingUniversity of Calgary502026-09-012026-06-03
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
flecainide, Sotalol or Amiodarone - Atrial Fibrillation (AF), Coronary Artery Disease
Phase 4RecruitingUniversitaire Ziekenhuizen KU Leuven9882026-09-012026-10-21
Pharmacological Intervention to Prevent NOAF After TAVR
Metoprolol succinate, Amiodarone - Atrial Fibrillation
Not applicableNot yet recruitingShanghai East Hospital1982026-04-072026-04-15
Comparative Efficacy of 100-, 200-, & 400-mg Amiodarone in Patients With Paroxysmal AF Depending on Plasma Concentration
Pharmacotherapy with amiodarone 200 mg per day, Treatment with Amiodarone at a dose 100 mg per day, Treatment with Amiodarone at a dose 400 mg per day - Paroxysmal AF, Treatment Decisions
Phase 4Enrolling by invitationTomsk National Research Medical Center of the Russian Academy of Sciences802026-01-122026-03-23
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
Amiodarone - Ventricular Arrhythmias and Cardiac Arrest
Phase 3RecruitingVersailles Hospital6742025-11-062025-12-23
Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
Amiodarone Hydrochloride 200 MG, Amiodarone Hydrochloride 100 MG - Persistent Atrial Fibrillation
Phase 4RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau3122025-11-012025-12-10
Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects
Amiodarone Hydrochloride Tablets, Febuxostat Tablets - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 1Not yet recruitingJemincare482025-10-302025-09-18
Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
Amiodarone, Minocycline - Atrial Fibrillation
Phase 2WithdrawnBaystate Medical Center2025-09-032026-09-30
Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies
Re-Do ventricular tachycardia ablation, Antiarrhythmic Drug Therapy (amiodarone, sotalol, or mexiletine) - Ventricular Tachycardia (VT)
Not applicableRecruitingIRCCS Ospedale San Raffaele512025-06-122026-03-27
BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery
topical amiodarone, saline solution patch - Atrial Fibrillation (AF)
Phase 3RecruitingJilin Heart Hospital5002025-02-152025-12-09
Early Amiodarone in Shockable Cardiac Arrest
Amiodarone Hydrochloride Injection, Usual Care Protocol - Cardiac Arrest
Phase 3RecruitingOregon Health and Science University5852025-01-012025-12-19
Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation
Amiodarone Injection, Sodium Chloride Injection 0.9% - Atrial Fibrillation (AF)
Not applicableNot yet recruitingShanghai Chest Hospital4182024-12-162024-12-19
Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation
Amiodarone (Antiarrhythmic drug) - Atrial Fibrillation (AF)
Phase 4Not yet recruitingInstitut Investigacio Sanitaria Pere Virgili1222024-12-102024-12-02
Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease
Eplereone - Atrial Fibrillation
Phase 1UnknownAssiut University1002024-08-102024-08-16
Heart Rhythm Changes in Patients With Atrial Fibrillation After Cardiopulmonary Bypass: a Retrospective Analysis
The tetralogy of medication regimen - Atrial Fibrillation
CompletedChinese Academy of Medical Sciences, Fuwai Hospital1062024-08-012025-08-22
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
Amiodarone Hydrochloride, Saline - Atrial Fibrillation, Esophageal Carcinoma
Phase 2RecruitingOHSU Knight Cancer Institute902024-06-212026-05-22
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
Amiodarone Hydrochloride 200 MG - Atrial Fibrillation New Onset
Phase 3RecruitingPopulation Health Research Institute4002024-06-132026-09-04
Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With Rapid Ventricular Response
Amiodarone - Atrial Fibrillation
Phase 4CompletedPolice General Hospital, Thailand242024-05-012025-01-22

Showing 20 of 120. Sign in to see all of them.

Conditions studied

Atrial Fibrillation (68)  ·  Arrhythmias, Cardiac (15)  ·  Tachycardia, Ventricular (14)  ·  Heart Arrest (7)  ·  Heart Diseases (7)  ·  Heart Failure (6)  ·  Ventricular Fibrillation (6)  ·  Cardiovascular Diseases (5)  ·  Atrial Flutter (4)  ·  Death, Sudden, Cardiac (4)  ·  Myocardial Ischemia (4)  ·  Cardiomyopathies (3)  ·  Sepsis (3)  ·  COVID-19 (2)  ·  Chagas Cardiomyopathy (2)

Sponsors

Mayo Clinic (3)  ·  National Heart, Lung, and Blood Institute (NHLBI) (3)  ·  Population Health Research Institute (3)  ·  University of Calgary (3)  ·  Advanz Pharma (2)  ·  Assiut University (2)  ·  Duke University (2)  ·  Hospital General Universitario Gregorio MaraƱon (2)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Indiana University (2)  ·  John Sapp (2)  ·  Ottawa Hospital Research Institute (2)  ·  Prism Pharmaceuticals (2)  ·  Sanofi (2)  ·  Shanghai Chest Hospital (2)

Countries

United States (35)  ·  Canada (19)  ·  France (10)  ·  China (9)  ·  Spain (7)  ·  Finland (6)  ·  Italy (6)  ·  Netherlands (6)  ·  Denmark (5)  ·  Poland (5)  ·  Russia (5)  ·  Czechia (4)  ·  Germany (4)  ·  Norway (4)  ·  Sweden (4)

Top investigators

Andrea Natale, MD (2)  ·  H. Greene (2)  ·  James E Tisdale, PharmD (2)  ·  William G Stevenson, MD (2)  ·  Alexandre Soeiro, MD (1)  ·  Alfred Hallstrom (1)  ·  Andrea Natale, M.D. (1)  ·  Andrew JE Seely, MD, PhD (1)  ·  Angel Arenal, MD, PhD (1)  ·  Anson Lee, MD (1)  ·  Anthony L Tang, MD FRCPC (1)  ·  Anthony S Tang, MSc, MD, FRCPC (1)

Results publications

PMID 10073786, PMID 10091823, PMID 10193563, PMID 10395122, PMID 10858380, PMID 11395591, PMID 12372573, PMID 12466507, PMID 12576943, PMID 12767648, PMID 12914883, PMID 15226218, PMID 1563883, PMID 15644659, PMID 15831645, PMID 15872201, PMID 16216756, PMID 16380589, PMID 17051439, PMID 1729329, PMID 17804851, PMID 18294562, PMID 18371559, PMID 18497594, PMID 18497597, PMID 18854540, PMID 19029470, PMID 19699916, PMID 19704100, PMID 19903189, PMID 19917887, PMID 19934423, PMID 20200016, PMID 20381077, PMID 20384650, PMID 20553056, PMID 2057525, PMID 2063768, PMID 20723644, PMID 20802247, PMID 20884379, PMID 21135293, PMID 21232669, PMID 21844082, PMID 22032709, PMID 22082672, PMID 22226423, PMID 2245612, PMID 22770549, PMID 23280225

NIH funding

2008 (3), 2025 (2), 2005 (1), 2023 (1), K23HL173647 (1), R01HL031472 (1), R34HL138110 (1), U01HL055766 (1), U01HL077863 (1), U01HL088942 (1)